Entrepreneur Bryan Johnson Diagnosed with Autoimmune Gastritis
創業家 Bryan Johnson 確診患有自體免疫性胃炎
Introduction
Bryan Johnson, a technology entrepreneur known for his focus on longevity, has announced that he has been diagnosed with autoimmune gastritis (AIG).
以專注長壽而聞名的科技創業家 Bryan Johnson 宣布，他被診斷患有自體免疫性胃炎 (AIG)。
Main Body
The 48-year-old entrepreneur received his diagnosis in May after experiencing low iron levels for a long time. Doctors confirmed the condition using a stomach camera (endoscopy), blood tests for specific antibodies, and five biopsies. AIG occurs when the immune system attacks the cells that produce stomach acid, which makes it difficult for the body to absorb vitamin B12 and iron. Consequently, this condition can lead to anemia and increase the risk of stomach cancer.
這位 48 歲的創業家在 5 月收到診斷結果，因為他長期以來鐵質水平偏低。醫生透過胃鏡檢查、特定抗體血液測試以及五次切片檢查確認了這項病情。當免疫系統攻擊分泌胃酸的細胞時，就會導致 AIG，使得身體難以吸收維生素 B12 和鐵質。因此，這種情況可能會導致貧血，並增加患胃癌的風險。
Johnson believes his autoimmune issues began at age 21 with a thyroid problem, which he attributes to a poor diet, work stress, and depression during his youth. He emphasized that AIG is often hidden for years because low iron levels may not be noticed until a person becomes anemic. Furthermore, medical experts like Dr. Rajdeep More have noted that while 'biohacking' does not cause AIG, extreme fasting or taking too many supplements can make nutritional deficiencies worse.
Johnson 認為他的自體免疫問題始於 21 歲時的甲狀腺問題，他將其歸咎於年輕時的飲食不良、工作壓力以及憂鬱。他強調 AIG 通常會潛伏多年，因為在一個人變得貧血之前，鐵質水平偏低的情況可能不會被察覺。此外，如 Dr. Rajdeep More 等醫療專家指出，雖然「生物駭客 (biohacking)」不會導致 AIG，但極端斷食或服用過多補充劑可能會使營養缺乏問題惡化。
There is a clear difference between standard medical views and Johnson's goals. While most doctors assert that AIG can be managed but not cured, Johnson believes that artificial intelligence and synthetic biology can make the condition curable. He plans to use AI-designed antibodies to try and reset his immune system, although these methods are still in the experimental stage and have not been fully proven.
標準醫療觀點與 Johnson 的目標之間存在明顯差異。雖然大多數醫生斷言 AIG 可以管理但無法治癒，但 Johnson 相信人工智慧和合成生物學可以使這種病情痊癒。他計劃利用 AI 設計的抗體來嘗試重設他的免疫系統，儘管這些方法目前仍處於實驗階段，尚未完全被證實。
Conclusion
Mr. Johnson plans to record and share his progress as he tries to treat the condition using these experimental methods.
Johnson 先生計劃記錄並分享他嘗試用這些實驗方法治療病情的進度。
Vocabulary Learning
⚡ The 'Causality' Shift: Moving from A2 to B2
At the A2 level, you probably use 'because' for everything. To reach B2, you need to express how one thing leads to another using a variety of connectors. This article is a goldmine for this transition.
🛠 The Tool: Logical Connectors
Look at how the text connects a medical cause to a result. Instead of saying "He has AIG because his immune system attacks his stomach," the text uses more sophisticated bridges:
-
Consequently Used to show a direct, logical result.
- Example: "AIG occurs... Consequently, this condition can lead to anemia."
- B2 Tip: Use this at the start of a sentence to sound more professional than 'so'.
-
Attributes to Used to assign a cause to a specific reason.
- Example: "...which he attributes to a poor diet."
- B2 Tip: Instead of saying "I think the reason is...", use "I attribute this to..."
-
Lead to Used to describe a progression toward a result.
- Example: "...can lead to anemia."
- B2 Tip: This is a 'dynamic' verb. It shows a journey from Cause Effect.
🔍 Contextual Vocabulary Expansion
To move past basic English, stop using general words like "bad" or "problem." Steal these precise B2 terms from the text:
| A2 Word | B2 Upgrade from Text | Why it's better |
|---|---|---|
| Bad diet | Poor diet | More formal and standard in health contexts |
| Problem | Condition / Deficiency | 'Condition' is for medical states; 'Deficiency' means something is missing |
| Say | Assert / Emphasize | 'Assert' shows confidence; 'Emphasize' shows importance |
💡 The 'Experimental' Grammar Note
Notice the phrase: "...methods are still in the experimental stage."
In A2, you might say "These methods are new." In B2, we use [Adjective] + [Noun] + [Stage/Phase]. Try this pattern: "My English studies are currently in the intermediate stage."